semaglutide effects on menstrual cycle A FAERS pharmacovigilance analysis published in Obstetrics & Gynecology found generated signals for heavy bleeding, menstrual clots, intermenstrual bleeding, oligomenorrhea, and anovulatory cycles in female patients aged 12 to 55 Does Semaglutide (GLP-1) Affect Your

Clinical studies show that patients using semaglutide can achieve an average weight reduction of up to 15% of their body weight over 68 weeks

This medication may be considered a safe option in people at risk of misuse, addiction, or dependence

For example, the SELECT trial reported that semaglutide reduced the risk of MACE by 20% (Hazard Ratio (HR) 0.80, 95% confidence interval (CI) 0.720.90) in people with obesity but without diabetes, although several secondary outcomes did not reach statistical significance under hierarchical testing procedures

Presented for research literature review only Wolff J et al

Mistake 2: skipping resistance training Many people view GLP-1 therapy as a weight loss solution and assume that the medication does all the work